1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 2: Angiographic and procedural characteristics
UK (n = 72) RT (n = 125) ICA occlusion 22 (30.5) 50 (40.0) Carotid-t occlusion 8 (11.0) 23 (18.4) MCA occlusion 50 (69.5) 75 (60.0) M1 occlusion 32 (44.5) 45 (36.0) M2 occlusion 18 (25.0) 30 (24.0) IA thrombolytic dose (median, range) 200,000 U (25,000–1,500,000 U) 2 mg (1–8 mg) Mechanical thrombolysis 43 (59.7) 90 (72.0) Clot disruption with microwire 18 37 Snare 2 3 Balloon 3 7 Balloon +stent 5 6 Merci 13 30 Penumbra 0 3 Merci + Penumbra 0 3 Merci + balloon + stent 2 1
-
Note:—Values in parentheses are percentages, except for IA thrombolytic dose.